INNOVATIONS IN DERMATOLOGIC SURGERY AND MELANOMA PATHOGENESIS: FROM THE PERSONALISED SURGERY TO THE CONCEPT OF GENOMIC MAPPING/ TARGETING VIA NITROSAMINES IN DRUGS: SPOTLIGHT ON CONTAMINATION OF ANGIOTENSIN CONVERTING ENZYME INHIBITORS (ACES) AND ANGIOTENSIN RECEPTOR BLOCKERS (ARBS)